We found a significant delay in primary tumor growth generated by 8505c (Fig. 5B, left panel) and CAL62 (Fig. 5B, right panel) cells in the DEL-22379-treated groups compared with animals treated with vehicle, but with greater potency in BRAF-mutant cells. This evidence concerns the gene BRAF and neoplasm.